Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,594 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strong Quantum Computational Advantage Using a Superconducting Quantum Processor.
Wu Y, Bao WS, Cao S, Chen F, Chen MC, Chen X, Chung TH, Deng H, Du Y, Fan D, Gong M, Guo C, Guo C, Guo S, Han L, Hong L, Huang HL, Huo YH, Li L, Li N, Li S, Li Y, Liang F, Lin C, Lin J, Qian H, Qiao D, Rong H, Su H, Sun L, Wang L, Wang S, Wu D, Xu Y, Yan K, Yang W, Yang Y, Ye Y, Yin J, Ying C, Yu J, Zha C, Zhang C, Zhang H, Zhang K, Zhang Y, Zhao H, Zhao Y, Zhou L, Zhu Q, Lu CY, Peng CZ, Zhu X, Pan JW. Wu Y, et al. Among authors: hong l. Phys Rev Lett. 2021 Oct 29;127(18):180501. doi: 10.1103/PhysRevLett.127.180501. Phys Rev Lett. 2021. PMID: 34767433
Quantum computational advantage via 60-qubit 24-cycle random circuit sampling.
Zhu Q, Cao S, Chen F, Chen MC, Chen X, Chung TH, Deng H, Du Y, Fan D, Gong M, Guo C, Guo C, Guo S, Han L, Hong L, Huang HL, Huo YH, Li L, Li N, Li S, Li Y, Liang F, Lin C, Lin J, Qian H, Qiao D, Rong H, Su H, Sun L, Wang L, Wang S, Wu D, Wu Y, Xu Y, Yan K, Yang W, Yang Y, Ye Y, Yin J, Ying C, Yu J, Zha C, Zhang C, Zhang H, Zhang K, Zhang Y, Zhao H, Zhao Y, Zhou L, Lu CY, Peng CZ, Zhu X, Pan JW. Zhu Q, et al. Among authors: hong l. Sci Bull (Beijing). 2022 Feb 15;67(3):240-245. doi: 10.1016/j.scib.2021.10.017. Epub 2021 Oct 25. Sci Bull (Beijing). 2022. PMID: 36546072
MUC16: clinical targets with great potential.
Zhang XY, Hong LL, Ling ZQ. Zhang XY, et al. Among authors: hong ll. Clin Exp Med. 2024 May 17;24(1):101. doi: 10.1007/s10238-024-01365-5. Clin Exp Med. 2024. PMID: 38758220 Free PMC article. Review.
Expert consensus on the clinical application of immunotherapy in breast cancer: 2024.
Wang K, Yang J, Wang B, Liu Q, Wang X, Yin Y, Wang H, Wang S, Hao C, Hao X, Liu Y, Jiang Z; Chinese Society of Clinical Oncology Breast Cancer Committee*; Chinese Society of Clinical Oncology Breast Cancer Committee. Wang K, et al. Transl Breast Cancer Res. 2024 Apr 29;5:9. doi: 10.21037/tbcr-24-15. eCollection 2024. Transl Breast Cancer Res. 2024. PMID: 38751677 Free PMC article. Review.
3,594 results